bendroflumethiazide has been researched along with Bone Diseases, Metabolic in 1 studies
Bendroflumethiazide: A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p810)
bendroflumethiazide : A sulfonamide consisting of 7-sulfamoyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by a trifluoromethyl group and that at position 3 is substituted by a benzyl group.
Bone Diseases, Metabolic: Diseases that affect the METABOLIC PROCESSES of BONE TISSUE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rejnmark, L | 1 |
| Vestergaard, P | 1 |
| Pedersen, AR | 1 |
| Heickendorff, L | 1 |
| Andreasen, F | 1 |
| Mosekilde, L | 1 |
1 trial available for bendroflumethiazide and Bone Diseases, Metabolic
| Article | Year |
|---|---|
Dose-effect relations of loop- and thiazide-diuretics on calcium homeostasis: a randomized, double-blinded Latin-square multiple cross-over study in postmenopausal osteopenic women.
Topics: Alkaline Phosphatase; Bendroflumethiazide; Biomarkers; Bone Diseases, Metabolic; Bumetanide; Calcium | 2003 |